U.S. Hospitality Stock News

NasdaqGS:LGIH
NasdaqGS:LGIHConsumer Durables

Assessing LGI Homes (LGIH) Valuation After A Year Of Weak Shareholder Returns

Why LGI Homes is on investors’ radar now LGI Homes (LGIH) has drawn attention after a period of weaker recent returns, including a 26.15% decline over the past month and a 41.79% total return decline over the past year. For investors tracking homebuilders, those moves, combined with annual revenue of US$1.71b and net income of US$72.55m, raise questions about how the business model and current valuation fit into a longer term portfolio view. See our latest analysis for LGI Homes. LGI Homes’...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Assessing Hasbro (HAS) Valuation After New Debt Issuance And Credit Facility Extension

Hasbro (HAS) has just completed a US$400 million senior notes offering with a 4.650% coupon due 2031 and extended its US$1.1 billion revolving credit facility to 2031, reshaping its funding profile. See our latest analysis for Hasbro. At a share price of US$95.78, Hasbro has seen a 19.9% 90 day share price return and a 55.2% 1 year total shareholder return. This suggests momentum has picked up even as the latest bond deal and headquarters move keep attention on balance sheet strength and...
NasdaqGS:MRCY
NasdaqGS:MRCYAerospace & Defense

Assessing Mercury Systems (MRCY) Valuation As Weaker Orders And Margins Raise Fresh Investor Concerns

Why Mercury Systems Is Back on Investors’ Radar Mercury Systems (MRCY) is drawing attention after sluggish order growth, falling operating margins, and pressure on earnings per share raised fresh questions about how durable its current business performance really is. See our latest analysis for Mercury Systems. At a share price of $89.36, Mercury Systems has seen a 24.35% 90 day share price return and a very strong 110.11% 1 year total shareholder return. This suggests momentum has been...
NasdaqGS:FLYW
NasdaqGS:FLYWDiversified Financial

Assessing Flywire (FLYW) Valuation After Analyst Upgrades And Strong Revenue And Profitability Results

Why Flywire is back on investors’ radar Flywire (FLYW) is drawing fresh attention after brokerage firms reiterated positive views and raised expectations, alongside the company’s latest quarterly report showing higher sales and a move into positive profitability. See our latest analysis for Flywire. Flywire’s share price has recently picked up, with a 1 week share price return of 9.09% and 1 month share price return of 20.53%, as investors react to its latest earnings, fresh guidance and...
NYSE:CWAN
NYSE:CWANSoftware

Assessing Clearwater Analytics Holdings (CWAN) Valuation After Mixed Short And Long Term Returns

Why Clearwater Analytics Holdings (CWAN) Is On Investors’ Radar Clearwater Analytics Holdings (CWAN) has drawn attention after recent trading left the stock with mixed returns, including a 1 day decline and gains over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for Clearwater Analytics Holdings. At a share price of $23.39, Clearwater Analytics has seen an 11.91% 90 day share price return. The 1 year total shareholder return of 15.25% and 3 year...
NasdaqGS:TSEM
NasdaqGS:TSEMSemiconductor

Assessing Tower Semiconductor (NasdaqGS:TSEM) Valuation As Photonics Partnership Progresses Toward AI Data Center Production

Why this new photonics partnership matters for Tower Semiconductor (NasdaqGS:TSEM) Tower Semiconductor (NasdaqGS:TSEM) has moved its collaboration with Salience Labs into pre-production for photonic optical circuit switches aimed at AI data centers, using its PH18DA and TPS45PH silicon photonics platforms. See our latest analysis for Tower Semiconductor. Against this backdrop, Tower Semiconductor’s recent move into photonic switches comes after a mixed run in the share price. A 1-day share...
NYSE:ROG
NYSE:ROGElectronic

What Does Webb’s 2026 Exit Mean for Rogers’ (ROG) Restructuring Execution and Management Bench?

Rogers Corporation recently announced that Senior Vice President and Chief Administrative Officer Michael Webb will leave the company on March 13, 2026, marking a significant change in its leadership team. This leadership transition comes as Rogers is already contending with questions about demand in key end markets and the execution of its restructuring plans. We’ll now examine how the broader market-driven move and this leadership change might affect Rogers’ existing investment...
NasdaqCM:IMTX
NasdaqCM:IMTXBiotechs

Is Immatics’ 2025 Loss and PRAME Pipeline Push Altering The Investment Case For Immatics (IMTX)?

Immatics N.V. has reported full-year 2025 results, swinging to a net loss of €196.45 million and a basic loss per share of €1.61 from continuing operations, while also outlining progress across its PRAME-targeting cell therapy pipeline. Beyond the headline loss, the company’s push to advance anzu-cel toward potential approval and expand PRAME programs like IMA203CD8 and IMA402 highlights an intensifying focus on PRAME as a central therapeutic axis across multiple tumor types. We will now...
NasdaqGS:CVBF
NasdaqGS:CVBFBanks

Regional Bank Selloff and Private Credit Scrutiny Might Change The Case For Investing In CVB Financial (CVBF)

In early March 2026, CVB Financial was caught up in a broader selloff of regional banks after Western Alliance Bancorporation disclosed a private credit–linked loan write-off that stoked concerns about opaque exposures across the sector. This episode has sharpened investor focus on hidden balance sheet risks at mid-sized lenders, particularly around how private credit ties could interact with existing loan books and capital strength. Next, we’ll examine how heightened scrutiny of private...
NYSE:GPC
NYSE:GPCRetail Distributors

A Look At Genuine Parts (GPC) Valuation After Its Planned Auto And Industrial Business Separation

Why Genuine Parts is back in focus after its business separation plan Genuine Parts (GPC) is back on investors’ radar after Raymond James upgraded the stock following the company’s decision to separate its auto and industrial businesses, using a sum of the parts approach. See our latest analysis for Genuine Parts. Genuine Parts’ share price has come under pressure recently, with a 30 day share price return of 24.69% and a year to date share price return of 9.81%, while the 1 year total...
NasdaqCM:NESR
NasdaqCM:NESREnergy Services

National Energy Services Reunited (NESR) Is Down 16.0% After Strong Q4 2025 Results And Jafurah Ramp

In recent weeks, National Energy Services Reunited Corp. reported strong Q4 and full-year 2025 results, with resilient margins supported by early activity at the Jafurah project and detailed in its latest 10-K filing. Analysts and research services have highlighted NESR’s improving earnings outlook and comparatively attractive valuation metrics, positioning it as a value-oriented oilfield services player in the MENA region with growing interest in sustainable solutions. Next, we’ll explore...
NYSE:ROK
NYSE:ROKElectrical

Is Rockwell Automation’s (ROK) New Bologna Hub Quietly Recasting Its Industrial Cybersecurity Edge?

In late February and early March 2026, Rockwell Automation opened a new Bologna Customer Experience Center for EMEA manufacturers and announced that wheel maker Ronal Group is standardizing global remote access using Rockwell’s secure, NIS2-aligned technology. Together, these moves highlight how Rockwell is pairing hands-on digital transformation support with strengthened industrial cybersecurity to deepen its role in customers’ operations. We’ll now examine how the Bologna center’s focus on...
NYSE:LH
NYSE:LHHealthcare

How Labcorp’s Upgraded EPS Outlook Amid Mixed Quarter Will Impact Labcorp Holdings (LH) Investors

In the most recent quarter, Labcorp reported year-on-year revenue growth but came in slightly below analyst expectations, while raising its full-year earnings per share guidance following strong results in its Diagnostics and Central Laboratory units. This guidance increase, underpinned by businesses that touch more than 600 million tests annually and were involved with 90% of 2023 FDA-approved drugs, highlights how core operations are shaping management’s confidence in the earnings...
NasdaqGS:PAX
NasdaqGS:PAXCapital Markets

A Look At Patria Investments (PAX) Valuation After Recent Share Price Weakness

How Patria Investments (PAX) Has Been Trading Recently Patria Investments (PAX) has drawn attention after a weak recent trading stretch, with the share price declining about 10% over the past week, 17% over the past month, and 25% over the past 3 months. For investors, those moves sit alongside a 1 year total return of about 14%. This raises the question of whether current levels around US$11.81 fairly reflect the company’s earnings profile and business model in private markets asset...
NasdaqGM:PRCT
NasdaqGM:PRCTMedical Equipment

Is PROCEPT’s Growth Targets And New CFO Director Altering The Investment Case For PROCEPT BioRobotics (PRCT)?

In late February 2026, PROCEPT BioRobotics reported fourth quarter and full-year 2025 results showing higher sales but a larger net loss, and issued 2026 guidance calling for US$390 million to US$410 million in revenue, gross margin of about 65%, and a net loss of US$78,500,000 to US$91,500,000. Alongside this guidance, the company outlined 2027 targets, including 25% to 30% annual revenue growth and 68% to 70% gross margin, and soon after expanded its board to nine members by appointing...
NYSE:VST
NYSE:VSTRenewable Energy

Assessing Vistra (VST) Valuation After New Nuclear Demand And Big Tech Power Deals

Vistra (VST) is back in focus after strong customer interest in its 1.8-gigawatt nuclear facility and new power purchase agreements with Amazon and Meta, along with more upbeat analyst commentary. See our latest analysis for Vistra. At a share price of US$163.62, Vistra has seen a 9.34% 1 month share price return and a very large 5 year total shareholder return. This suggests momentum has been strong despite some shorter term dips as investors reassess earnings and clean energy contract...
NasdaqGS:COST
NasdaqGS:COSTConsumer Retailing

Costco Fertility Care Partnership Tests Member Value And Rich Valuation

Costco Wholesale (NasdaqGS:COST) has entered a partnership with Sesame and IVI RMA North America to expand affordable fertility care options for members. The collaboration offers coordinated access to fertility specialists, nationwide support, and discounts on related medications. The program is positioned as an extension of Costco's existing pharmacy and health offerings into more specialized care. For Costco, known primarily for its warehouse retail model and membership structure, this...
NasdaqGS:HSIC
NasdaqGS:HSICHealthcare

How Investors May Respond To Henry Schein (HSIC) Earnings, Buybacks And New AI-Enabled Dentrix Ascend Packages

Henry Schein, Inc. recently reported fourth-quarter 2025 results showing sales of US$3,437 million and net income of US$101 million, alongside full-year 2025 sales of US$13.18 billion and net income of US$398 million, while also booking a US$15 million intangible asset impairment and completing a sizeable share repurchase program. At the same time, Henry Schein One introduced new Dentrix Ascend cloud packages built on an integrated, AI-enabled platform and the company issued 2026 sales...
NasdaqGS:RARE
NasdaqGS:RAREBiotechs

How Setrusumab Trial Setbacks and Securities Suits May Impact Ultragenyx Pharmaceutical (RARE) Investors

In past months, several law firms announced securities class actions against Ultragenyx Pharmaceutical, alleging the company misled investors about the reliability and risks of Phase III Orbit and Cosmic trials for setrusumab in osteogenesis imperfecta, after the studies failed to reach statistical significance. The litigation raises questions about Ultragenyx’s clinical disclosure practices and could influence how investors view the company’s risk profile, capital allocation, and future...
NasdaqGS:KRYS
NasdaqGS:KRYSBiotechs

The Bull Case For Krystal Biotech (KRYS) Could Change Following Q4 Beat And CEO Stock Sales

In recent weeks, Krystal Biotech reported financial results for the fourth quarter of 2025 that exceeded analyst expectations for both earnings and revenue, while President and CEO Krishnan Krish S executed US$6.58 million of pre-planned stock sales under a Rule 10b5-1 trading plan. This combination of financial outperformance and insider selling offers fresh insight into how management is monetizing equity while the core business appears to be executing ahead of external forecasts. Next,...
NasdaqGS:MELI
NasdaqGS:MELIMultiline Retail

MercadoLibre (MELI) Valuation Check After Earnings Highlight Margin Pressures And Fintech Expansion

MercadoLibre (MELI) recently drew fresh attention after its fourth quarter and full year 2025 earnings, reporting strong revenue and fintech traction but tighter margins as costs, loss reserves, and competition in Brazil picked up. See our latest analysis for MercadoLibre. Those earnings and margin concerns have quickly fed into the share price, with MercadoLibre now trading at US$1,769.52 after a 10.2% 1 month share price decline and a 9% 1 year total shareholder return. The 3 year total...
NasdaqGS:FIVE
NasdaqGS:FIVESpecialty Retail

Assessing Five Below (FIVE) Valuation After Strong Earnings Momentum And Technical Strength

Recent commentary around Five Below (FIVE) focuses on its accelerating earnings, consistent EPS beats, solid sales growth, and cash flow strength, with the stock also showing constructive technical action that has caught investors’ attention. See our latest analysis for Five Below. Alongside its latest store opening in New Hampshire and recent technical strength flagged by market watchers, Five Below’s 1-month share price return of 8.5% and 90-day share price return of 25.4% sit against a...
NYSE:SNDR
NYSE:SNDRTransportation

Assessing Schneider National (SNDR) Valuation After Mixed Short Term Share Performance

Schneider National stock snapshot after recent performance Schneider National (SNDR) has seen mixed share performance recently, with a modest 1 day gain alongside declines over the past week and month, prompting investors to reassess its transportation and logistics profile. See our latest analysis for Schneider National. At a share price of $25.79, Schneider National’s recent 7 day and 30 day share price returns of 8.42% and 12.52% declines contrast with a 1 year total shareholder return of...
NYSE:APAM
NYSE:APAMCapital Markets

A Look At Artisan Partners Asset Management (APAM) Valuation After Recent Share Price Weakness

How Artisan Partners Asset Management stock has been performing Artisan Partners Asset Management (APAM) has attracted attention after a period of weaker share performance, with the stock showing a 0.9% decline over the past day and a 17.9% decline over the past month. Over the past 3 months, Artisan Partners Asset Management has recorded an 11.1% decline, while the year to date return stands at a 10.6% decline and the 1 year total return at a 4.5% decline. Looking further back, the 3 year...